CLINICAL_TRIALS
trial_result
· 2012-10-19
Clinical Trial Update: Safety and Efficacy of MP-424 to Treat Chronic Hepatitis C [Phase 2]
Summary
Phase 2 trial results evaluating MP-424 for chronic hepatitis C, reporting safety and efficacy outcomes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tanabe Pharma Corporation | Conditions: Hepatitis C | Phase 2 | Status: COMPLETED | Results posted: 2012-10-19